MeSH term
Frequency | Condition_Probility | Adult | 6 | 0.0 |
Child | 3 | 0.0 |
Chromosome Deletion | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Humans | 37 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
*Mutation | 2 | 0.0 |
Phenotype | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Animals | 18 | 0.0 |
Cell Differentiation | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Mice | 11 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 2 | 1.0 |
Trans-Activators/biosynthesis/*genetics | 2 | 9.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Cell Line | 4 | 0.0 |
Conserved Sequence | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 4 | 0.0 |
Female | 9 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Trans-Activators/*genetics | 4 | 1.0 |
Zinc Fingers | 3 | 0.0 |
Syndrome | 3 | 0.0 |
Male | 7 | 0.0 |
Cell Differentiation/genetics/immunology | 2 | 2.0 |
Cells, Cultured | 3 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Th2 Cells/*cytology/*immunology/metabolism | 2 | 66.0 |
Adolescent | 2 | 0.0 |
Aged | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Family Health | 2 | 0.0 |
Kidney/*abnormalities | 2 | 8.0 |
Middle Aged | 5 | 0.0 |
Pedigree | 3 | 0.0 |
DNA Methylation | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Deafness/*genetics | 2 | 1.0 |
Hypoparathyroidism/*genetics | 2 | 25.0 |
Base Sequence | 7 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Interleukin-4/biosynthesis | 2 | 1.0 |
Interleukin-5/biosynthesis | 2 | 5.0 |
Mice, Transgenic | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Comparative Study | 7 | 0.0 |
Gene Library | 4 | 0.0 |
Mutation | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
*Oncogene Proteins | 2 | 3.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Cytokines/*biosynthesis | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Transfection | 2 | 0.0 |
Interleukin-10/biosynthesis | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Th2 Cells/*metabolism | 2 | 8.0 |
*Nuclear Proteins | 2 | 0.0 |
